Shares of Nurix Therapeutics crashed Wednesday after Sanofi unexpectedly scrapped an experimental eczema drug that two were codeveloping. The post Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real